EssilorLuxottica Société anonyme (EL.PA) Stock Analysis

EssilorLuxottica is the global leader in ophthalmic lenses, frames and sunglasses, combining Essilor’s lens technology with Luxottica’s brands, manufacturing and retail distribution. Its integrated model spans Professional Solutions, which supplies ECPs and distributors, and Direct-to-Consumer, which operates more than 17,000 stores and digital channels including Ray-Ban.com and Oakley.com. **Underlying execution is strong:** H1 2026 revenue reached €14,818 million, up 9.7% at constant exchange rates, adjusted operating profit rose 15.0% to €2,751 million and constant-FX adjusted operating margin expanded 80 basis points to 18.9%. Free cash flow reached a five-year high of €1,067 million. **The strategic upside comes from smart eyewear and med-tech:** Ray-Ban Meta and Oakley Meta sold over 7 million units in FY 2025, while Stellest myopia revenue grew 24% in Q2 2026. The stock is priced at €140.35, or 17.7x normalized P/E and 11.48x EV/EBITDA, below its historical 25x–32x P/E range. The central valuation debate is whether currency pressure and qualitative guidance conceal durable growth or signal a lower-growth regime. Catalysts include euro stabilization, Stellest US adoption, Nuance Audio Gen 2 and wearable scale-driven margin leverage. The report’s base case targets €239.80 in 2030, while its probability-weighted target is €253.93.